Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth - PubMed (original) (raw)

Review

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

D Roberts et al. Cochrane Database Syst Rev. 2006.

Update in

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
Roberts D, Brown J, Medley N, Dalziel SR. Roberts D, et al. Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3. Cochrane Database Syst Rev. 2017. PMID: 28321847 Free PMC article. Updated. Review.

Abstract

Background: Respiratory distress syndrome (RDS) is a serious complication of preterm birth and the primary cause of early neonatal mortality and disability.

Objectives: To assess the effects on fetal and neonatal morbidity and mortality, on maternal mortality and morbidity, and on the child in later life of administering corticosteroids to the mother before anticipated preterm birth.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (30 October 2005).

Selection criteria: Randomised controlled comparisons of antenatal corticosteroid administration (betamethasone, dexamethasone, or hydrocortisone) with placebo or with no treatment given to women with a singleton or multiple pregnancy, expected to deliver preterm as a result of either spontaneous preterm labour, preterm prelabour rupture of the membranes or elective preterm delivery.

Data collection and analysis: Two review authors assessed trial quality and extracted data independently.

Main results: Twenty-one studies (3885 women and 4269 infants) are included. Treatment with antenatal corticosteroids does not increase risk to the mother of death, chorioamnionitis or puerperal sepsis. Treatment with antenatal corticosteroids is associated with an overall reduction in neonatal death (relative risk (RR) 0.69, 95% confidence interval (CI) 0.58 to 0.81, 18 studies, 3956 infants), RDS (RR 0.66, 95% CI 0.59 to 0.73, 21 studies, 4038 infants), cerebroventricular haemorrhage (RR 0.54, 95% CI 0.43 to 0.69, 13 studies, 2872 infants), necrotising enterocolitis (RR 0.46, 95% CI 0.29 to 0.74, eight studies, 1675 infants), respiratory support, intensive care admissions (RR 0.80, 95% CI 0.65 to 0.99, two studies, 277 infants) and systemic infections in the first 48 hours of life (RR 0.56, 95% CI 0.38 to 0.85, five studies, 1319 infants). Antenatal corticosteroid use is effective in women with premature rupture of membranes and pregnancy related hypertension syndromes.

Authors' conclusions: The evidence from this new review supports the continued use of a single course of antenatal corticosteroids to accelerate fetal lung maturation in women at risk of preterm birth. A single course of antenatal corticosteroids should be considered routine for preterm delivery with few exceptions. Further information is required concerning optimal dose to delivery interval, optimal corticosteroid to use, effects in multiple pregnancies, and to confirm the long-term effects into adulthood.

PubMed Disclaimer

Comment in

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
Neilson JP. Neilson JP. Obstet Gynecol. 2007 Jan;109(1):189-90. doi: 10.1097/01.aog.0000251610.51286.b1. Obstet Gynecol. 2007. PMID: 17233108 No abstract available.

Cited by

Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth.
Gyamfi-Bannerman C, Gilbert S, Landon MB, Spong CY, Rouse DJ, Varner MW, Meis PJ, Wapner RJ, Sorokin Y, Carpenter M, Peaceman AM, O'Sullivan MJ, Sibai BM, Thorp JM, Ramin SM, Mercer BM; Eunice Kennedy Shriver National Institute of Child Health; Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Gyamfi-Bannerman C, et al. Obstet Gynecol. 2012 Mar;119(3):555-9. doi: 10.1097/AOG.0b013e31824758f6. Obstet Gynecol. 2012. PMID: 22353953 Free PMC article.
Insulin and glucagon levels of umbilical cord blood in appropriate for gestational age - preterm infants with or without postnatal hypoglycemia.
Park JH, Bae JG, Kim S, Kim CS, Lee SL, Kim HS. Park JH, et al. Ann Pediatr Endocrinol Metab. 2016 Jun;21(2):86-91. doi: 10.6065/apem.2016.21.2.86. Epub 2016 Jun 30. Ann Pediatr Endocrinol Metab. 2016. PMID: 27462585 Free PMC article.
Antenatal corticosteroids trial in preterm births to increase neonatal survival in developing countries: study protocol.
Althabe F, Belizán JM, Mazzoni A, Berrueta M, Hemingway-Foday J, Koso-Thomas M, McClure E, Chomba E, Garces A, Goudar S, Kodkany B, Saleem S, Pasha O, Patel A, Esamai F, Carlo WA, Krebs NF, Derman RJ, Goldenberg RL, Hibberd P, Liechty EA, Wright LL, Bergel EF, Jobe AH, Buekens P. Althabe F, et al. Reprod Health. 2012 Sep 19;9:22. doi: 10.1186/1742-4755-9-22. Reprod Health. 2012. PMID: 22992312 Free PMC article. Clinical Trial.
Antenatal glucocorticoids and neonatal inflammation-associated proteins.
Faden M, Holm M, Allred E, Fichorova R, Dammann O, Leviton A; ELGAN Study Investigators. Faden M, et al. Cytokine. 2016 Dec;88:199-208. doi: 10.1016/j.cyto.2016.09.015. Epub 2016 Sep 24. Cytokine. 2016. PMID: 27668972 Free PMC article. Clinical Trial.
Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
Cools F, Offringa M, Askie LM. Cools F, et al. Cochrane Database Syst Rev. 2015 Mar 19;2015(3):CD000104. doi: 10.1002/14651858.CD000104.pub4. Cochrane Database Syst Rev. 2015. PMID: 25785789 Free PMC article. Review.

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth - PubMed (original) (raw)